Biointron is thrilled to announce our participation in CPHI Japan 2025, one of Asia’s most influential pharmaceutical events, set to take place from April 9-11, 2025, in Tokyo, Japan.

Biointron is delighted to announce our participation in the NextGen Biomed Europe 2025 Conference, happening on March 12-14, 2025, in London, UK.

Biointron is excited to announce our participation in the World ADC London 2025 Conference, set to take place March 3-6, 2025, in London, UK.

Biointron is thrilled to announce that Biointron will be participating in the upcoming 24th Annual PepTalk Protein Science Conference, taking place January 13-16, 2025, in San Diego, California.

On Friday December 13th, 2024, Biointron marked the end of a milestone year with a spectacular annual year-end networking party at Davio's Northern Italian Steakhouse in Boston. Bringing together industry professionals, partners, and clients, the event celebrated Biointron’s achievements and ho

The 22nd Annual Discovery on Target 2024 was held in Boston, MA on September 30 to October 3, 2024. This four-day event involved discussion on popular topics like kinases, immunomodulation, and degraders, plus coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models.

The 15th Annual World Bispecifics Summit 2024 was held in Boston, MA on September 3-5, 2024. The event brought together experts in the field of bi, tri and multi-specifics, in addition to bispecific ADCs and BiTEs.

The 12th Immuno-Oncology Summit 2024 was held in Philadelphia, PA on August 7-9, 2024. The annual event serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology.

BIO Asia 2024 was held in Taiwan on 24-28 July, 2024. The event brought together bioindustry leaders from North America, Europe and Asia to explore business opportunities and to engage with Taiwan's emerging biotech sector. This year’s theme, Global View, Asian Touch, showcased the opportunities that exist within Asian’s fast-moving economies, its dynamic and innovation-generating biomedical ecosystems, and its globally-connected bioindustry production and value chains.

BIOPLUS-INTERPHEX KOREA 2024 was held in Seoul, Korea on July 10-12, 2024. The bio-pharmaceutical exhibition had keynote sessions, over 30 conferences, partnering, open innovation, and networking opportunities to expand overseas by building global business networks. → Biointron’s Highlighted

The 7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference 2024 was held in Boston, MA on 20-21 June, 2024. The event brought together academics and scientists from research institutes and biopharmaceutical companies to discuss the latest updates, challenges, and future directions in immuno-oncology research.

Antibody Engineering & Therapeutics Europe 2024 was held in London, UK on 4-6 June, 2024. As Europe's leading antibody conference for accelerating next-generation antibodies to commercial success, topics discussed included:Emerging modalities: ADCs, degraders, and beyondFc

The BIO International Convention 2024 was held in San Diego, CA from June 3-6. It is the largest event for biotechnology with over 18,500 industry leaders in attendance, sharing the latest advancements in the industry. The most popular topics included:AI and Digital HealthNext Generation

The 20th Annual PEGS Boston Summit 2024 was held in Boston, MA from May 13-17. During the event, industry experts from across the world gathered to share the latest research in advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, mu

Highlights from CAS 2024: advancements in cancer immunotherapy, Alzheimer’s therapies, protein bioinformatics, & novel antibody engineering technologies.